Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed

The summary for the Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.
Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed: The Food and Drug Administration announces its intention to consider and accept a renewal application for award to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The purpose of this program is to provide support in convening regional pharmaceutical regulatory authorities and pharmaceutical industry associations representing regions and jurisdictions from around the world to achieve greater harmonization of scientific and technical standards for pharmaceuticals. This is to ensure that safe, effective, and high-quality medicines are developed and registered in the most resource-efficient manner, to be available to patients globally. The outcome of this effort will be a series of internationally recognized guidelines for pharmaceutical product registration, adopted by regulators in regions around the world.
Federal Grant Title: Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed
Federal Agency Name: Food and Drug Administration (HHS-FDA)
Grant Categories: Consumer Protection, Food and Nutrition, Health, Science and Technology and other Research and Development
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-FD-21-002
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.103
CFDA Descriptions: Information not provided
Current Application Deadline: October 13th, 2020
Original Application Deadline: October 13th, 2020
Posted Date: July 8th, 2020
Creation Date: July 8th, 2020
Archive Date: November 12th, 2020
Total Program Funding: $2,500,000
Maximum Federal Grant Award: $500,000
Minimum Federal Grant Award:
Expected Number of Awards: 1
Cost Sharing or Matching: No
Last Updated: July 8th, 2020
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Eligible Organizations International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Additional Information on Eligibility:Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the HHS Grants Policy Statement, are allowed.
Link to Full Grant Announcement
Full Announcement RFA-FD-21-002
Grant Announcement Contact
Shashi Malhotra
Grants Management Specialist
Phone 2404027592
shashi.malhotra@fda.hhs.gov
Similar Government Grants
Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 C...
Smoking Machine Adaptor Design Project for ENDS, Cigars, and Heated Tobacco Products (UC2)...
CBER FY20 FOA for AAV vector manufacturing for diseases affecting very small populations (...
Drug Development Science Support (U01) Clinical Trials Optional
Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Tre...
Support for Small Scientific Conference Grant Program
Cooperative Agreement to Support the World Health Organization (WHO) International Program...
Clinical Studies of Safety and Effectiveness of Orphan Products
More Grants from the Food and Drug Administration
Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 C...
Smoking Machine Adaptor Design Project for ENDS, Cigars, and Heated Tobacco Products (UC2)...
CBER FY20 FOA for AAV vector manufacturing for diseases affecting very small populations (...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020 FederalGrants.com